Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy - PubMed (original) (raw)
Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy
Stephen B Tucker et al. J Am Acad Dermatol. 2006 Jun.
Abstract
Background: Interferon alfa-2b (IFN) may be used to treat basal cell carcinoma (BCC) as an alternative to surgical or destructive methods.
Objective: The purpose of this study is to determine the long-term effectiveness of IFN treatment for BCC.
Methods: Fifty patients with 98 biopsy-proven primary superficial and nodular BCCs were treated perilesionally and intradermally with injections of IFN between 1985 and 1992.
Results: Clinical cures were noted in 95 of 98 BCCs (51 nodular and 44 superficial), with a mean follow-up period of 10.5 years (9 months to 18.5 years). Of these, 35 of the 50 patients, which would include 68 of the 98 tumors, were followed up for a minimum of 10 years, with an average follow-up of 13.5 years. The 3 lesions requiring further treatment were nodular type BCC. One of these lesions showed no response to treatment, whereas the other two responded, then recurred at 4 and 154 months. Of the 68 tumors followed up for a minimum of 10 years, cure rates were 96%. Overall data analysis using Kaplan-Meier estimates showed 98% success rates at years 5 and 10, and a 96% success rate at year 15.
Limitations: Since 31% of patients could not be evaluated for more than 10-year follow-up, it is possible that the long-term cure rate is lower than that found in those available for evaluation.
Conclusions: Treatment of superficial and nodular BCCs with perilesional IFN is an acceptable treatment that may provide benefits over other treatment modalities depending on patients' individual needs. In addition, on the basis of this study, results of IFN treatment for BCC are comparable to most other methods of tumor destruction.
Similar articles
- Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon.
Sánchez V, Carpio E, Fardales VE, Martínez B, Arias AI, Brito E, Bermudez N, Rodríguez Y. Sánchez V, et al. An Bras Dermatol. 2024 May-Jun;99(3):391-397. doi: 10.1016/j.abd.2023.08.009. Epub 2024 Feb 20. An Bras Dermatol. 2024. PMID: 38383261 Free PMC article. - Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D, Matías-Guiu X, Alomar A. Vidal D, et al. Clin Exp Dermatol. 2004 Sep;29(5):518-25. doi: 10.1111/j.1365-2230.2004.01601.x. Clin Exp Dermatol. 2004. PMID: 15347339 Clinical Trial. - Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma.
Alpsoy E, Yilmaz E, Başaran E, Yazar S. Alpsoy E, et al. J Dermatol. 1996 Jun;23(6):394-6. doi: 10.1111/j.1346-8138.1996.tb04040.x. J Dermatol. 1996. PMID: 8708151 Clinical Trial. - Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K, Etzkorn J, Cohen G. Chitwood K, et al. Dermatol Surg. 2013 Sep;39(9):1306-16. doi: 10.1111/dsu.12300. Epub 2013 Aug 5. Dermatol Surg. 2013. PMID: 23915332 Review.
Cited by
- Interventions for basal cell carcinoma of the skin.
Thomson J, Hogan S, Leonardi-Bee J, Williams HC, Bath-Hextall FJ. Thomson J, et al. Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD003412. doi: 10.1002/14651858.CD003412.pub3. Cochrane Database Syst Rev. 2020. PMID: 33202063 Free PMC article. - Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Hochmann S, Mittermeir M, Santic R, Koszik F, Griessner L, Sonderegger AS, Hoffmann T, Russe E, Scheiblhofer S, Weiss R, Mandler M, Schneeberger A, Strunk D. Hochmann S, et al. Sci Rep. 2018 Aug 28;8(1):12954. doi: 10.1038/s41598-018-31061-w. Sci Rep. 2018. PMID: 30154486 Free PMC article. - Clinical variants, stages, and management of basal cell carcinoma.
Dourmishev LA, Rusinova D, Botev I. Dourmishev LA, et al. Indian Dermatol Online J. 2013 Jan;4(1):12-7. doi: 10.4103/2229-5178.105456. Indian Dermatol Online J. 2013. PMID: 23439912 Free PMC article. - Skin cancer of the head and neck.
Ouyang YH. Ouyang YH. Semin Plast Surg. 2010 May;24(2):117-26. doi: 10.1055/s-0030-1255329. Semin Plast Surg. 2010. PMID: 22550432 Free PMC article. - Nonsurgical innovations in the treatment of nonmelanoma skin cancer.
Amini S, Viera MH, Valins W, Berman B. Amini S, et al. J Clin Aesthet Dermatol. 2010 Jun;3(6):20-34. J Clin Aesthet Dermatol. 2010. PMID: 20725548 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical